🇺🇸 FDA
Pipeline program

Inactivated Poliomyelitis vaccine (IMOVAX)

IPV25

Phase 2 mab completed

Quick answer

Inactivated Poliomyelitis vaccine (IMOVAX) for Poliomyelitis is a Phase 2 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Poliomyelitis
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials